# Oleaceae plants: a source of metabolites with atheroprotective potential

**Authors:** Agnieszka Filipek, Edyta Czepielewska

PMC · DOI: 10.3389/fphar.2025.1721433 · Frontiers in Pharmacology · 2026-02-11

## TL;DR

Oleaceae plants contain bioactive compounds that may help prevent atherosclerosis by reducing inflammation and oxidative stress.

## Contribution

This review identifies Oleaceae phytochemicals as multi-targeted agents with potential for atheroprotective applications.

## Key findings

- Oleaceae metabolites activate antioxidant pathways and inhibit inflammation.
- Preclinical studies show strong anti-atherosclerotic effects of these compounds.
- Polyphenol-rich olive oil is linked to improved cardiovascular health in clinical evidence.

## Abstract

Atherosclerosis is a leading cause of cardiovascular morbidity and mortality, driven by chronic inflammation, oxidative stress, lipid imbalance, and plaque instability. Bioactive metabolites found in plants of the Oleaceae family, particularly olives (Olea europaea L.), have emerged as promising modulators of these processes. This narrative review highlights several key phytochemicals, such as oleacein and oleuropein (secoiridoids), hydroxytyrosol and oleocanthal (phenylethanoids), acteoside and syringin (phenylpropanoids), oleanolic and ursolic acids (triterpenoids), phillygenin (lignans), caffeic and chlorogenic acids (phenolic acids). These metabolites act by activating the Nrf2/HO-1 antioxidant defence pathway, inhibiting NF-κB-driven inflammation, regulating cholesterol transport (ABCA1/ABCG1 and CD36), protecting the endothelium, and stabilising atherosclerotic plaque. Preclinical studies consistently demonstrate strong anti-atherosclerotic activity, while clinical evidence mainly supports the consumption of polyphenol-rich extra virgin olive oil, which has been linked to improved endothelial function, reduced oxidative and inflammatory markers, and a lower risk of cardiovascular disease. However, robust trials of purified compounds and non-olive Oleaceae species are lacking. Oleaceae-derived phytochemicals offer multi-targeted cardioprotective potential, but their translation into clinical applications remains limited.

Diagram illustrating various natural compounds and their associated plant images around a central theme of "Anti-Atherosclerosis". Compounds listed include oleuropein, hydroxytyrosol, oleacein, and others, with benefits such as antioxidant, anti-inflammatory, and endothelial protection.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], HMOX1 (heme oxygenase 1) [NCBI Gene 3162], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], ABCA1 (ATP binding cassette subfamily A member 1) [NCBI Gene 19], ABCG1 (ATP binding cassette subfamily G member 1) [NCBI Gene 9619], CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948]
- **Chemicals:** oleacein (PubChem CID 18684078), oleuropein (PubChem CID 5281544), hydroxytyrosol (PubChem CID 82755), oleocanthal (PubChem CID 11652416), acteoside (PubChem CID 5281800), syringin (PubChem CID 5316860), oleanolic acid (PubChem CID 10494), ursolic acid (PubChem CID 64945), phillygenin (PubChem CID 3083590), caffeic acid (PubChem CID 689043), chlorogenic acid (PubChem CID 1794427)
- **Diseases:** atherosclerosis (MONDO:0005311), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** Hmgcs1 (3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1) [NCBI Gene 208715] {aka B130032C06Rik}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Apoa1 (apolipoprotein A-I) [NCBI Gene 11806] {aka Alp-1, Apoa-1, Brp-14, Ltw-1, Lvtw-1, Sep-1}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Pcsk9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 100102] {aka FH3, HCHOLA3, Narc1, PC9}, Ldlr (low density lipoprotein receptor) [NCBI Gene 16835] {aka Hlb301}, Olr1 (oxidized low density lipoprotein (lectin-like) receptor 1) [NCBI Gene 108078] {aka LOX-1, SR-EI, Scare1}, Hdac11 (histone deacetylase 11) [NCBI Gene 232232], Scarb1 (scavenger receptor class B, member 1) [NCBI Gene 20778] {aka CD36, Cd36l1, Chohd1, Cla-1, Cla1, D5Ertd460e}, LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, Nr1h3 (nuclear receptor subfamily 1, group H, member 3) [NCBI Gene 22259] {aka LXR, RLD1, Unr1}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Abcg1 (ATP binding cassette subfamily G member 1) [NCBI Gene 11307] {aka Abc8, White}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Abca1 (ATP-binding cassette, sub-family A member 1) [NCBI Gene 11303] {aka ABC-1, Abc1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Srebf2 (sterol regulatory element binding factor 2) [NCBI Gene 20788] {aka SREBP-2, SREBP2, SREBP2gc, bHLHd2, lop13, nuc}, Cyba (cytochrome b-245, alpha polypeptide) [NCBI Gene 13057] {aka b558, nmf333, p22-phox, p22phox}, Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Gusb (glucuronidase, beta) [NCBI Gene 110006] {aka Gur, Gus, Gus-r, Gus-s, Gus-t, Gus-u}
- **Diseases:** necrotic (MESH:D009336), atherosclerotic plaque (MESH:D058226), hypotension (MESH:D007022), chronic arterial ischemia (MESH:D007511), osteoarthritis (MESH:D010003), intermittent claudication (MESH:D007383), chronic (MESH:D002908), hypercholesterolemia (MESH:D006937), heart failure (MESH:D006333), infarct (MESH:D007238), Obesity (MESH:D009765), bleeding (MESH:D006470), embolism (MESH:D004617), type 2 diabetes (MESH:D003924), peripheral artery disease (MESH:D058729), inflammatory cytokines (MESH:D000080424), hepatic steatosis (MESH:D005234), stroke (MESH:D020521), coronary artery disease (MESH:D003324), overweight (MESH:D050177), IRH (MESH:D006940), dysfunction (MESH:D006331), endothelial dysfunction (MESH:D014652), diabetes (MESH:D003920), ischemic stroke (MESH:D002544), cancer (MESH:D009369), plaques (MESH:D003773), heart attack (MESH:D009203), Alzheimer's disease (MESH:D000544), cardiovascular death (MESH:D002318), arterial thrombi (MESH:D012078), prediabetes (MESH:D011236), toxicity (MESH:D064420), platelet aggregation (MESH:D001791), cardiometabolic diseases (MESH:D024821), thrombosis (MESH:D013927), hyperglycemia (MESH:D006943), proinflammatory diseases (MESH:D004194), Inflammation (MESH:D007249), acute coronary syndrome (MESH:D054058), coronary heart disease (MESH:D003327), Atherosclerosis (MESH:D050197), hypertension (MESH:D006973), dyslipidemia (MESH:D050171)
- **Chemicals:** Caffeic acid (MESH:C040048), simvastatin (MESH:D019821), Oleuropein (MESH:C002769), aglycone (MESH:C458179), NAD+ (MESH:D009243), TXB2 (MESH:D013929), glycosides (MESH:D006027), lapatinib (MESH:D000077341), Hydroxytyrosol (MESH:C005975), ROS (MESH:D017382), sulfuric acid (MESH:C033158), calcium (MESH:D002118), quinic acid (MESH:D011801), glucose (MESH:D005947), Chlorogenic acid (MESH:D002726), Cholesterol (MESH:D002784), NOx (MESH:D009569), Oleoacteoside (MESH:C551366), Oleanolic acid (MESH:D009828), elenolic acid (MESH:C000352), Erythrodiol (MESH:C077953), kaempferol (MESH:C006552), monacolin K (MESH:D008148), amides (MESH:D000577), polyphenol (MESH:D059808), water (MESH:D014867), phenol (MESH:D019800), OH (MESH:C031356), Ursolic acid (MESH:C005466), thromboxane A2 (MESH:D013928), PGE2 (MESH:D015232), Phillygenin (MESH:C542294), LPS (MESH:D008070), Oleocanthal (MESH:C503534), Phenolic acids (MESH:C017616), arachidonic acid (MESH:D016718), lipid (MESH:D008055), 8-epi prostaglandin-F2alpha (MESH:C075750), prostaglandins (MESH:D011453), forsythoside B (MESH:C552409), homocysteine (MESH:D006710), carboxylic acid (MESH:D002264), Syringin (MESH:C028305), dexamethasone (MESH:D003907), 3-hydroxyphenylpropionic acid (MESH:C491266), thiol (MESH:D013438), hydroxycinnamic acids (MESH:D003373), m-coumaric acid (MESH:C043332), HVA (MESH:D006719), Lignans (MESH:D017705), tamoxifen (MESH:D013629), MUFA (MESH:D005229), LPO (MESH:D008054), phytosterols (MESH:D010840), oil (MESH:D009821), MDA (MESH:D008315), erucic alcohol (MESH:C027036), DOPAC (MESH:D015102), Oleacein (MESH:C578055), tartaric acid (MESH:C029768)
- **Species:** Cistanche deserticola (species) [taxon 161395], Fraxinus excelsior (European ash, species) [taxon 38873], Forsythia viridissima (species) [taxon 205691], gut metagenome (species) [taxon 749906], Jasminum officinale (common jasmine, species) [taxon 126433], Forsythia suspensa (species) [taxon 126418], Cistanche tubulosa (species) [taxon 161397], Jasminum mesnyi (Japanese jasmine, species) [taxon 105898], Syringa vulgaris (common lilac, species) [taxon 34270], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Mus musculus (house mouse, species) [taxon 10090], Ligustrum lucidum (species) [taxon 458695], Rattus norvegicus (brown rat, species) [taxon 10116], Olea (olives, genus) [taxon 4145], Oleaceae (olive famly, family) [taxon 4144], Enterovirus C (no rank) [taxon 138950], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Olea europaea (common olive, species) [taxon 4146], Ligustrum vulgare (common privet, species) [taxon 13597], Forsythia x intermedia (cultivated forsythia, species) [taxon 55183], Malus domestica (apple, species) [taxon 3750]
- **Mutations:** proline-arginine, C-12-C, A to K
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932613/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12932613/full.md

## References

216 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932613/full.md

---
Source: https://tomesphere.com/paper/PMC12932613